How to Read a Peptide Certificate of Analysis

A certificate of analysis is a formal quality document issued by an analytical laboratory stating that a named lot of material has been tested by specified methods and that the results either meet or fall outside stated acceptance criteria. For a research peptide, the COA accompanies a specific shipment and provides the only record-level link between the vial a researcher holds and the analytical data generated before release.

The distinction between a lot-specific COA and a product-level specification sheet matters considerably. A specification sheet describes what a material is supposed to be and the ranges it is expected to meet across batches. A COA reports what a specific lot actually measured. Only the latter is useful for quality assessment of received material, because only the latter is tied to the lot number on the label.

A COA that lists methods without numerical results, or that lists results without stating which methods produced them, falls short of that standard. Equally limited is a document that carries a product name but no lot number, or one that cannot be obtained directly from the testing laboratory rather than only through the distributor. These gaps are not necessarily indicative of fraud but are reliable indicators that the document's informational value is restricted.

Identity testing answers whether the material in the vial is the claimed compound. For synthetic peptides, this is almost always done by mass spectrometry, which compares an observed molecular mass against the theoretical mass calculated from the amino acid sequence. A positive identity result requires the observed mass to fall within a stated tolerance of the theoretical value - typically a few tenths of a dalton for smaller peptides.

The COA should state the molecular formula or theoretical mass used as the reference, the observed mass or mass-to-charge ratio, the instrument type or method - such as ESI-MS or MALDI-TOF - and whether the result passed or failed acceptance. A document that states only "Identity: Conforms" without any numerical data provides no basis for independent verification.

Identity by mass spectrometry confirms that the molecular weight is consistent with the claimed compound. It does not by itself confirm sequence, stereochemistry, or the absence of isomeric substitutions that share the same nominal mass. For compounds where those distinctions matter, additional analytical evidence such as fragmentation data or amino acid analysis would be expected alongside the basic mass confirmation.

Purity for synthetic peptides is most commonly reported as a percentage derived from reversed-phase high-performance liquid chromatography. The figure represents the area occupied by the principal peak as a fraction of the total peak area in the chromatogram. This is an area-percent figure rather than a mass-percent figure, and the distinction has practical consequences discussed in detail in the companion guide on HPLC purity.

A substantive purity entry on a COA includes the method: the column chemistry and dimensions, the mobile phase composition and gradient profile, the detection wavelength, and the run time. These details allow an independent laboratory to reproduce the analysis and assess whether the conditions would resolve the impurities most likely to arise from the synthesis of the specific compound. Without them, the percentage figure cannot be meaningfully evaluated.

The purity result should also be specific to the lot. A COA that lists a typical or representative purity figure, or that states purity as a range consistent with the product specification, is reporting a specification rather than a measured result. Lot-specific chromatographic data, or the chromatogram itself where available, provides a far stronger basis for acceptance decisions.

Most COAs include an appearance entry, typically describing lyophilised peptides as a white to off-white powder or solid. This test is conducted by visual inspection against a written specification, and while it is straightforward, it provides a useful check: material that arrives discoloured, visibly degraded, or in an unexpected physical form warrants documentation and prompt follow-up with the supplier.

Water content is a more analytically substantive entry. Lyophilisation removes bulk water but cannot eliminate it entirely, and residual moisture affects both the practical mass of peptide per vial and the stability of the material during storage. Water content is commonly determined by Karl Fischer titration, and a well-documented COA will state both the method and the numerical result - typically expressed as a percentage by mass.

Net peptide content follows from water content, counterion content, and purity taken together. A vial labelled as containing a stated milligram quantity of peptide may contain considerably less actual peptide by mass once those factors are accounted for. The COA provides the data needed to perform that calculation, but carrying it out is the responsibility of the receiving laboratory rather than a figure that should be assumed from the label alone.

Synthetic peptides are purified using organic solvents - most commonly acetonitrile and trifluoroacetic acid - and traces of those solvents can remain in the lyophilised product. Residual solvent testing, typically by gas chromatography, characterises the quantity of each solvent present and whether it falls within limits appropriate for the intended research application.

Counterion content is particularly relevant for peptides purified by reversed-phase HPLC using trifluoroacetic acid as an ion-pairing modifier. The resulting peptide salt carries a trifluoroacetate counterion, and its proportion directly affects how much of the stated vial mass is peptide versus salt. A COA that provides counterion content - often expressed as the trifluoroacetate percentage - enables more precise mass accounting than a document that omits it.

Both residual solvents and counterion data should be lot-specific. Counterion content in particular varies between synthesis runs and cannot be reliably assumed from a product-level average. Research applications that depend on precise mass quantities should require this data as a standard component of acceptance documentation rather than regarding it as optional supplementary information.

The lot number is the element that connects the COA to the physical material. It should appear on the vial label, on the shipping documentation, and in the body of the COA itself. A document whose lot number does not match the received material is not the COA for that material, regardless of how complete its analytical data appear.

Dates carry their own informational load. The manufacture or synthesis date, the analytical testing date, and the expiry or retest date should each be present. The testing date should be recent relative to shipment - analytical data generated long before the lot was shipped, or before the lot number was assigned, raises questions about whether the document reflects the specific material provided. The expiry or retest date sets the outer boundary of the material's documented shelf life under stated storage conditions.

Document issuance information - the testing laboratory name and location, the authorising analyst or quality officer, and ideally a version or document number - completes the traceability record. For institutions that must demonstrate chain of custody of research materials, retaining the original COA alongside receipt records and internal inventory logs is standard practice and a reasonable expectation from internal audit or institutional review processes.